Treatment of refractory chronic urticaria: current and future therapeutic options. - Wikidata - wikimedia - TriplyDB

Treatment of refractory chronic urticaria: current and future therapeutic options.

Treatment of refractory chronic urticaria: current and future therapeutic options.

http://www.wikidata.org/entity/Q38148494

about

Management of urticaria: not too complicated, not too simple Treatment of Refractory Chronic Urticaria The relation of autologous serum and plasma skin test results with urticarial activity score, sex and age in patients with chronic urticaria.Chronic urticaria: new management options.Omalizumab for the treatment of chronic urticaria.Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases.Current and future therapies for treating chronic spontaneous urticaria.Management of chronic spontaneous urticaria in the elderly.Effective treatment of different phenotypes of chronic urticaria with omalizumab: Case reports and review of literature.Pneumocystis jirovecii pneumonia induced by low-dose methotrexate in a patient with chronic urticaria.Phototherapy using narrowband ultraviolet B and psoralen plus ultraviolet A is beneficial in steroid-dependent antihistamine-refractory chronic urticaria: a randomized, prospective observer-blinded comparative study.Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update.Management and treatment of chronic urticaria (CU).

P2860

Q26828373-7251C71C-6925-4DE8-9C72-512C75D0140B Q26865314-EF2F41B0-2A28-4775-BEB9-EA5BC579276D Q35829124-F09BF244-6007-466A-AD2C-B1B3268C03B4 Q38266463-B14E9A60-44D6-4146-A518-39D12DC64BAE Q38310407-DDCDF65C-1DEF-4F8D-8BB0-DE9FBB0299DC Q38360827-DC0430A3-1666-416C-9F27-768C8ACEBFA4 Q38751342-1F626A32-4395-4A74-9A98-D888C1B7F2D9 Q41103892-02550CAE-3491-4A71-B18D-E35FBAA605C8 Q43470423-BCC43D96-858C-4C21-8037-D06A8DD1AAF3 Q47150407-3573FB95-ED5E-4F15-BFFC-CB7F503C397C Q48213522-7F2CDE2B-A2FF-466B-9BA5-C363BCB4D8F3 Q52661824-12278E9B-625E-4101-BA4F-44B353A8A875 Q52938044-7A563AB2-4DD7-4DF7-95FB-C0BC399D9543

P2860

Treatment of refractory chronic urticaria: current and future therapeutic options.

http://www.wikidata.org/entity/Q38148494

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Treatment of refractory chronic urticaria: current and future therapeutic options.

@en

type

label

Treatment of refractory chronic urticaria: current and future therapeutic options.

@en

prefLabel

Treatment of refractory chronic urticaria: current and future therapeutic options.

@en

P1433

Q38148494-ECF4E91F-6F0F-44F3-85C2-5BBF2EDFFDC5

P1476

Q38148494-1D17F35C-F845-4E66-B919-18F7B6973ECA

P2093

Q38148494-0CD81EF4-C545-495D-93EB-00C5565563E8

Q38148494-0F7E41A6-2B8F-4DFB-9A7A-B35470B9EAB7

P2860

Q38148494-005560F2-C129-4D28-AA96-628A701FA287

Q38148494-061833CB-FDD3-43B5-9135-C133D530AF42

Q38148494-0AAF372E-E672-421D-A13B-3DE1413086F5

Q38148494-139A4232-452B-4719-9A7F-88401A8D6653

Q38148494-17A6ECFF-46D1-4DA0-969F-7B24A94DA03B

Q38148494-24C8B2F2-1DD5-40F1-A160-A1F5B79FD622

Q38148494-269A58B2-69E3-4D98-812E-2A32B9366C6B

Q38148494-2932F6D3-83FD-4B97-BCF3-384D009B8193

Q38148494-2BF3B026-0C0F-45AE-AF32-7B7D1B2564A5

Q38148494-3A18A663-7CDA-4B74-9DA0-B56C6ED40CD3

P2888

Q38148494-793B7738-67AC-4E7F-A1F4-4AB2CA256EB4

P304

Q38148494-98E425DE-3579-44CA-BE96-CBAE685125DB

P31

Q38148494-75CF4A2A-9BFA-463A-A066-52DF3C2964B0

P356

Q38148494-58F8309D-5C4D-41F4-9D4B-BAC04AE05A78

P433

Q38148494-CE8857E7-B64A-4383-AEFD-7FB754E1EEF6

P478

Q38148494-E2DDB18B-6213-4942-873B-4274F9F6539A

P50

Q38148494-A7848324-A234-4415-B9C3-667044451213

P577

Q38148494-9E297B0B-66D9-4351-9BA0-B253DA537B98

P6179

Q38148494-9FE8657F-8942-4034-A731-B7E65796FFE5

P698

Q38148494-6BC0D77E-83E6-4B13-B35D-EE66CC3BDFF1

P356

S40257-013-0047-3

P1433

American Journal of Clinical Dermatology

P1476

Treatment of refractory chronic urticaria: current and future therapeutic options.

@en

P2093

Alberto Tedeschi

http://www.w3.org/2001/XMLSchema#string

Riccardo Asero

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic

GRADE guidelines: 3. Rating the quality of evidence

Urticaria treated with dapsone.

Omalizumab-induced reductions in mast cell Fce psilon RI expression and function.

Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.

The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study.

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.

Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine.

Treatment of chronic autoimmune urticaria with omalizumab.

P2888

s40257-013-0047-3

P304

481-488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40257-013-0047-3

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1038907161

http://www.w3.org/2001/XMLSchema#string

P698

24085572

http://www.w3.org/2001/XMLSchema#string